Dr. Pero specializes in organic synthesis, specifically with carbohydrate and glycomimetic chemistry and also runs the Company’s feruloyl glycerides production. During his graduate studies, Dr. Pero investigated therapeutic alternatives to antibiotics by synthesizing carbohydrate mimetics for two pathogenic lectins – FimH in uropathogenic ¬E. coli and Fap2 in F. nucleatum. Dr. Pero brings an in-depth understanding of infection initiation and the role that carbohydrates play in the interaction between the host and pathogen. He received a Ph.D. in Organic Chemistry from the University of Connecticut in 2022 and a B.S. in Biochemistry from Saginaw Valley State University in 2017.
